Evidence map›Paper›PMID 34444219›Full record

SynthesisInternational journal of environmental research and public health2021

Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19.

Alison Munro, Hazel Booth, Nicola M Gray, Joan Love, Andrea R M Mohan, Jason Tang, Steve MacGillivray

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alison MunroDrug Harms Prevention Research Group, School of Health Sciences, University of Dundee, Dundee DD1 6HN, UK.
Hazel BoothFaculty of Social Sciences, University of Stirling, Stirling FK9 4LA, UK.
Nicola M GrayDrug Harms Prevention Research Group, School of Health Sciences, University of Dundee, Dundee DD1 6HN, UK.
Joan LoveDrug Harms Prevention Research Group, School of Health Sciences, University of Dundee, Dundee DD1 6HN, UK.
Andrea R M MohanDrug Harms Prevention Research Group, School of Health Sciences, University of Dundee, Dundee DD1 6HN, UK.
Jason TangDrug Harms Prevention Research Group, School of Health Sciences, University of Dundee, Dundee DD1 6HN, UK.
Steve MacGillivrayDrug Harms Prevention Research Group, School of Health Sciences, University of Dundee, Dundee DD1 6HN, UK.
University of Dundee · GBUniversity of Stirling · GB

Funding

Scottish Government DDTFRF03
6 · The paper itself

Abstract

People who use drugs (PWUD) experience many social and health harms and are considered at greater risk of acquiring COVID-19. Little research has examined the impact of coronaviruses either on PWUD, or on services targeted to PWUD. We report the findings of a systematic review of empirical evidence from studies which have examined the impact of coronaviruses (Severe Acute Respiratory Syndrome (SARS-CoV-1) and Middle Eastern Respiratory Syndrome (MERS-CoV) and COVID-19) on PWUD or on service responses to them. Five databases were searched (MEDLINE, PsycINFO, CINAHL, ASSIA and EMBASE) as well as COVID-19 specific databases. Inclusion criteria were studies reporting any impact of SARS, MERS or COVID-19 or any service responses to those, published between January 2000 and October 2020. Weight of Evidence judgements and quality assessment were undertaken. In total, 27 primary studies were included and grouped by seven main themes: treatment/recovery services; emergency medical settings; low-threshold services; prison setting, PWUD/substance use disorder (SUD) diagnosis; people with SUD and HIV; 'Sexual minority' men. Overall, research in the area was scant, and of average/poor quality. More robust research is required to inform on-going and future responses to coronavirus epidemics for PWUD.

Indexed as

COVID-19Pharmaceutical PreparationsDisease OutbreaksHumansPublic PolicySARS-CoV-2Pharmaceutical PreparationscoronavirusCOVID-19MERSpeople who use drugsproblem drug usersSARSservice responsessystematic review

Identifiers

PMID34444219
PMCPMC8394531
OpenAlexW3192018578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.